International Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813663) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Jazz Pharmaceuticals

Condition: Healthy Participants

Intervention: Drug: JZP269

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: September 22, 2026

Target Sample Size: 188

To know more, visit https://clinicaltrials.gov/study/NCT07813663...